Join our team

Current available jobs worldwide.

Read more

News and Features

5-6-19: Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s

1-4-19: Lundbeck Initiates Phase II Study of Potential New Treatment of Schizophrenia

Access all stories

Progress in Mind

Lundbeck is dedicated to raising awareness and research into psychiatric and neurological disorders. 

 

Learn more on our corporate website
You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck.